Effects of Amantadine Sulfate on Cognitive Impairments in Patients with Parkinson’s Disease |
| |
Authors: | A Yu Yablonskaya N V Fedorova M E Belgusheva |
| |
Institution: | 1.Moscow,Russia;2.Moscow,Russia |
| |
Abstract: | Cognitive impairments in patients with Parkinson’s disease (PD) lead to occupational, social, and psychological maladaptation
of patients and their relatives. This article presents the epidemiology, structure, and nature of cognitive impairments in
PD; the main pathogenetic factors involved in the development of moderate cognitive impairment and dementia in PD are discussed,
as are the methods of diagnosis and assessment of cognitive impairments and approaches to the correction of memory and intellectual
impairments. Results obtained from our own studies of the effects of treatment with amantadine sulfate at a dose of 300 mg
for 6 months on changes in cognitive impairments in 25 patients with PD are presented. Treatment results were evaluated using
neuropsychological questionnaire and scales (Mini Mental State Evaluation, Frontal Assessment Battery, Matiss Dementia Rating
Scale). In patients with PD and moderate cognitive impairments, six months of treatment with amantadine sulfate produced significant
improvements in neuropsychological test results. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|